Search Results for: alef


Aleafia Health Launching Kin Slips Cannabis-Infused Sublingual Strips

Kin Slips™, award-winning cannabis infused sublingual strips with a 10-minute onset time, are currently produced and sold under license exclusively in California Agreement provides exclusive Canadian rights to Aleafia Health to manufacture, market and sell Kin Slips, using proprietary formulations, manufacturing methodology and intellectual property Kin Slips will be launched in medical and adult-use markets  […]


MJardin’s Atlantic Canada Cultivation & Extraction Facility Receives Sales Licence

Phase 2 Expansion to be complete January 2020 TORONTO and DENVER, Jan. 08, 2020 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, is pleased to announce its AtlantiCann Medical Inc. (“AMI”)  facility has been awarded a sales licence from Health Canada. AMI is […]


Aleafia Health Provides Update Regarding Product Shipment

TORONTO, Dec. 20, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has received an update from a third-party transportation company (the “Carrier”) regarding a shipment of Aleafia Health’s packaged, finished cannabis products intended for the adult-use market. The authorized Carrier was in possession of the […]


MJardin Group Granted Cannabis Cultivation License by Health Canada for Nova Scotia Facility

DENVER — MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, is pleased to announce that the recently opened cultivation and extraction facility in Lower Sackville, Nova Scotia owned by AtlantiCann Medical Inc. (“AMI”), in which MJardin has a 50% equity interest, has been granted a license by Health Canada for […]


Aleafia Health Completes $7.1M Cannabis Sale Agreement

TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has reached a definitive Cannabis Material Purchase Agreement (the “Agreement”) on November 29, 2019, with a Canadian Licensed Producer. Under the terms of the Agreement, Aleafia Health will sell 2,840 kg of dried cannabis […]


Aleafia Health Launches International Medical Cannabis White Label Services

TORONTO, Nov. 28, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed production of its first white label production run of medical cannabis oils, for distribution in Australia. The cannabis oils were produced at the Company’s Paris Processing Facility and will be distributed by […]


Aleafia Health’s FoliEdge Academy Launching Cannabis Education Courses at a Major Post-Secondary Institution

TORONTO, Nov. 19, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly-owned subsidiary FoliEdge Academy, has entered into an Educational Products Distribution Agreement with one of the largest Canadian post-secondary institutions to introduce cannabis education courses and programs. The partner institution announcement and courses launch […]


Aleafia Health Receives Health Canada Approval to Expand Processing, Sell New Product Formats at Paris Facility

Health Canada licence amendment doubles licensed processing area  Company can also now produce and sell edibles, topicals and extracts Final site evidence package for Paris Phase II expansion has been submitted TORONTO, November 14, 2019 – Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly owned subsidiary, Emblem Cannabis […]


Aleafia Health Reports First Profitable Third Quarter

Ultra low-cost production at $0.08 cost per gram at outdoor facility Average net revenue per gram equivalent of $15.11 for medical cannabis sales Medical cannabis sales up 43% Q/Q, adult-use cannabis sales up 53% Q/Q Active, registered medical cannabis patients increase 48% Q/Q $57M in cash/marketable securities, $83M in working capital Total expenses decrease 30% […]


Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram

Cannabinoid content per gram only slightly lower than identical strains grown indoors Critical quality control tests successful Approximately 1,000 kg yield per acre in Zone 1 Expanded 3.7M sq. ft. outdoor site expected to produce approximately 102,000 kg in 2020 at full capacity TORONTO, November 11, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, […]


Aleafia Health Announces Termination of Supply Agreement With Aphria Inc.

TORONTO, Oct. 08, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announces that it has provided Aphria Inc. (TSX: APHA, NYSE: APHA) (“Aphria”) with a formal notice of the termination, effective October 7, 2019, of the wholesale cannabis supply agreement (the “Supply Agreement”) dated September […]


Aleafia Health Completes Construction, Secures Full Occupancy at Paris Processing Facility Expansion

Features initial 115,000 kg of dried flower equivalent annual extraction capacity, with ability for further expansion on-site 2,775% increase over Company’s current annual extraction capacity of 4,000 kg Brant County granted full occupancy of expanded facility on October 4 Final stage of securing Licence Amendment underway, with site evidence package to be submitted to Health […]


Aleafia Health Appoints New Lead Independent Director

TORONTO, Oct. 02, 2019 (GLOBE NEWSWIRE) — The Board of Directors of Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has appointed Lea Ray as its new Lead Independent Director.  As previously announced on April 4, 2019, the role rotates among independent directors every six months, as determined by […]


NEW AGE GAINS APPROVAL FROM JAPANESE GOVERNMENT TO LAUNCH CBD

DENVER, COLORADO, Sept. 24, 2019 (GLOBE NEWSWIRE) — New Age Beverages Corporation (NASDAQ: NBEV), the Colorado-based organic and natural products company, announced the approval by the Japanese Narcotics Control Division and the Japanese Ministry of Health for New Age’s CBD products in Japan and the company’s subsequent launch into the market effective immediately. New Age […]


Aleafia Health Provides Guidance for Profitable Third Quarter 2019

Company maintains strong balance sheet with $51 million in cash on hand Construction of Paris Phase II Processing facility expected to be completed in October 2019 Active, registered patients increased to over 10,000, a 42% increase since July Products grown, extracted and exported by Aleafia Health now available to patients in Australia TORONTO, Sept. 24, […]


Aleafia Health Expands Outdoor Cannabis Facility by Additional 60 Acres with Property Acquisition

New property cost $1.2 million and is directly adjacent to current Port Perry Outdoor Grow facility Company subsidiary, Emblem, also closes sale of unused Brant, Ont. property for $8.2 million in net cash TORONTO, Sept. 04, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”)’s wholly […]


Aleafia Health Reports Record Revenue in Q2 2019, 159% Q/Q Revenue Increase

Q/Q gross profit increases to $2.9M from -$0.1M in previous quarter Q/Q expenses decrease 41% Adjusted EBITDA improves to loss of $2.7 million Strong balance sheet with $58M cash on hand 8,861 registered patients at August 13, 2019, from 6,959 at June 30, 2019 Over 65,000 clinic patients seen to date TORONTO , Aug. 14, […]


Aleafia Health to Announce 2019 Second Quarter Financial Results

TORONTO, Aug. 07, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) will announce its 2019 Second Quarter Financial Results on August 14, 2019 at 7 a.m. EST. The Company will also host its Second Quarter Results Call the same day at 8:30 a.m. EST. The […]


Aleafia Health Completes Largest Cannabis Order to Date, Provides Facility Update

TORONTO, Aug. 01, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is announcing that its wholly owned subsidiary, Emblem Cannabis Corporation, has completed the largest adult-use cannabis order (the “Order”) in the Company’s history. The value of the Order is expected to generate proceeds from […]


Aleafia Health Completes Largest Cannabis Order to Date, Provides Facility Update

Single Product Order Surpasses Aleafia Health’s Entire 2018 Revenue from Cannabis Sales Niagara Greenhouse Cultivation Licence Application now Officially Under Review by Health Canada 13,000 Cannabis Plants Growing at Port Perry Outdoor Facility Including in Newly Licensed Zone 2 TORONTO, Aug. 01, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) […]


Aleafia Health Added to NYSE-Listed The Cannabis ETF

TORONTO, July 11, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has been added to The Cannabis ETF (NYSE: THCX) (“THCX”), which trades on the New York Stock Exchange. THCX seeks to track the Innovation Labs Cannabis Index which is a portfolio of 35 stocks […]


YIELD GROWTH Announces Definitive Agreement for Exclusive Distribution of Urban Juve Products in Greece and Cyprus

VANCOUVER, BC / ACCESSWIRE / July 11, 2019 / The Yield Growth Corp. (OTCQB:BOSQF) (CSE:BOSS) (Frankfurt:YG3) is pleased to announce it has entered into a definitive agreement on July 10, 2019 with Melorganics Hellas for distribution of Urban Juve products in Greece and Cyprus. Urban Juve to Launch in Greece & Cyprus Pursuant to the agreement […]


Aleafia Health Secures Health Canada Permits to Export Cannabis Products to Australia

TORONTO, July 02, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has received multiple Export Permits (the “Permits”) from Health Canada, which allow the Company to begin its first international cannabis product shipment. The Company expects to ship its branded medical cannabis oils in the […]


Aleafia Health Announces Closing of $40.25 Million Public Offering, Including Full Exercise of the Over-Allotment Option

TORONTO, June 27, 2019 (GLOBE NEWSWIRE) — (TSX: ALEF) (OTC: ALEAF) (FRA:ARAH) Aleafia Health Inc. (“Aleafia Health” or the “Company”) is pleased to announce that it has closed its previously announced public offering of convertible debenture units (the “Convertible Debenture Units”) of the Company at a price of $1,000 per Convertible Debenture Unit for aggregate gross […]


MJardin’s Atlantic Canada Facility Completes Multiple Harvests at Full Capacity

TORONTO and DENVER, June 26, 2019 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), is pleased to announce its AtlantiCann Medical Inc. (“AMI”) facility has reached full production capacity at three harvests per month with consistent yields and is ahead of schedule for reaching its annual target rates. “AMI” […]


Aleafia Health Secures Outdoor Cultivation Licence, Commences Planting of First Outdoor Crop

TORONTO, June 10, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has been granted approval by Health Canada for outdoor cannabis cultivation. On June 7, 2019, the Company’s wholly-owned subsidiary Aleafia Farms Inc., was granted a new Standard Cultivation License (the “Licence”) issued under Health […]


Aleafia Health Announces $35 Million Public Offering of 8.5% Convertible Debenture Units

TORONTO, June 06, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (“Aleafia Health” or the “Company”) (TSX: ALEF) (OTC: ALEAF) (FRA:ARAH) is pleased to report that its offering, previously announced on June 5, 2019, (the “Offering”) will be for an offering size of $35,000,000. The Offering will be conducted on an agency basis for the issuance […]


Aleafia Health Announces Public Offering of 8.5% Convertible Debenture Units

TORONTO, June 05, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (the “Aleafia Health”) (TSX: ALEF) (OTC: ALEAF) (FRA:ARAH) is pleased to announce that it has filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with the securities regulatory authorities in all provinces of Canada (except Québec) in connection with a proposed […]


Aleafia Health Reports First Quarter Results, Provides Corporate Update

TORONTO, ON, May 13, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to provide a corporate update and report its First Quarter 2019 financial results for the period ended March 31, 2019. Aleafia Health has filed today its consolidated financial statements and related management’s discussion […]


Aleafia Health Welcomes Changes to Cannabis Licensing, Completes Largest Ever Product Sale

TORONTO, ON, May 9, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed the largest adult-use cannabis order (the “Order”) in the Company’s history today. The Order is scheduled to depart from the Company’s facility today, with delivery to a Canadian provincial government for distribution to […]



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading